Influence of chronic azithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma

Influence of chronic azithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma

Abstract Background This study of the oropharyngeal microbiome complements the previously published AZIthromycin in Severe ASThma (AZISAST) clinical trial, where the use of azithromycin was assessed in subjects with exacerbation-prone severe asthma. Here, we determined the composition of the orophar...

Full description

Bibliographic Details
Main Authors: Guido Lopes dos Santos Santiago, Guy Brusselle, Kenny Dauwe, Pieter Deschaght, Chris Verhofstede, Dries Vaneechoutte, Ellen Deschepper, Paul Jordens, Guy Joos, Mario Vaneechoutte
Format: Article
Language:English
Published: BMC 2017-05-01
Series:BMC Microbiology
Subjects:
Asthma
Oropharyngeal microbiome
Azithromycin
Antibiotic treatment
Oral microbiome
Online Access:http://link.springer.com/article/10.1186/s12866-017-1022-6

Internet

http://link.springer.com/article/10.1186/s12866-017-1022-6

Similar Items